Urosepsis Management (EAU 2024 + SSC 2021)
Urosepsis Management (EAU 2024 + SSC 2021): Suspected Urosepsis → ⚠️ RECOGNIZE SEPSIS - TIME CRITICAL → SSC Hour-1 Bundle - START IMMEDIATELY → Empiric ...
Interactive Decision Tree
Algorithm Steps
- ▶Start
Suspected Urosepsis
UTI with systemic inflammatory response
- ⚠Warning
⚠️ RECOGNIZE SEPSIS - TIME CRITICAL
qSOFA: RR≥22, SBP≤100, altered mental status
- qSOFA ≥2 = high mortality risk
- SOFA score for organ dysfunction
- Fever, rigors, flank pain, pyuria
- Signs of shock: hypotension, tachycardia, mottling
- Altered mental status = late sign
- High index of suspicion in elderly/immunocompromised
- ●Action
SSC Hour-1 Bundle - START IMMEDIATELY
Do all within 1 hour of recognition
- 1. Measure lactate (repeat if >2)
- 2. Blood cultures BEFORE antibiotics
- 3. Broad-spectrum IV antibiotics
- 4. 30mL/kg crystalloid if hypotensive/lactate≥4
- 5. Vasopressors if MAP<65 despite fluids
- NEVER delay antibiotics for cultures
- ●Action
Empiric Antibiotic Selection (EAU 2024)
Broad coverage, adjust based on cultures
- Community: Ceftriaxone 2g IV + Aminoglycoside
- OR Piperacillin-tazobactam 4.5g IV q6h
- Healthcare-associated: Add MRSA/Pseudomonas coverage
- Carbapenem if ESBL risk or severe
- Meropenem 1g IV q8h
- De-escalate based on culture results
- ◆Decision
Obstructed Infected System?
Critical decision - source control needed
- ⚠Warning
⚠️ URGENT SOURCE CONTROL
Decompression saves lives (EAU Strong Rec)
- Antibiotics CANNOT sterilize obstructed system
- Must decompress to survive
- Options: Nephrostomy tube OR Ureteral stent
- Choice depends on patient stability and expertise
- Do within hours, not days
- Definitive stone treatment LATER
- ●Action
Percutaneous Nephrostomy
Often preferred in unstable patients
- US or CT guided
- Local anesthesia usually sufficient
- Avoids general anesthesia
- Direct decompression of renal pelvis
- Send pus for culture
- Higher success in dilated system
- ●Action
ICU-Level Care
For septic shock or organ dysfunction
- Vasopressors: Norepinephrine first-line
- Target MAP ≥65 mmHg
- Central venous access
- Arterial line for BP monitoring
- Lactate clearance as marker
- Consider stress-dose steroids if refractory
- ●Action
Ongoing Monitoring
Track response to treatment
- Serial lactate (should decrease)
- Urine output (target >0.5mL/kg/hr)
- Mental status improvement
- Temperature trending down
- WBC and inflammatory markers
- Culture results - narrow antibiotics
- ●Action
Definitive Treatment
After stabilization
- Stone removal once sepsis resolved
- Typically wait 2-4 weeks
- Transition to oral antibiotics
- Total duration: 7-14 days
- Address underlying cause
- Evaluate for structural abnormalities
- ✓Outcome
Outcomes
Mortality 20-40% if delayed treatment
- Early recognition + treatment: <10% mortality
- Delayed decompression: 20-40% mortality
- Key: antibiotics + source control FAST
- Long-term: address stone/obstruction cause
- ●Action
Retrograde Ureteral Stent
Alternative decompression
- Requires cystoscopy (brief GA/sedation)
- May not pass if stone impacted
- Internal drainage
- Less invasive long-term
- Consider if stable and experienced OR
- ●Action
Non-Obstructed Urosepsis
Antibiotics and supportive care
- Continue IV antibiotics
- Aggressive fluid resuscitation
- ICU if hemodynamically unstable
- Look for other sources (prostatitis, abscess)
- Renal/perinephric abscess may need drainage
- Emphysematous pyelonephritis high mortality
- ●Action
Urgent Imaging
Identify obstructed system
- CT abdomen/pelvis (non-contrast OK for obstruction)
- US if CT not immediately available
- Look for: hydronephrosis, stone, abscess
- Pyonephrosis = purulent obstructed system
- Air in collecting system concerning
- Do NOT delay source control for imaging
Guideline Source
EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Does not replace ICU-level sepsis management
- Antibiotic choice depends on local resistance patterns
- Complex cases require multidisciplinary input
- Does not address pediatric urosepsis
- Immunocompromised patients may present atypically
Contraindicated Populations
Applicable Regions
AU: Australian Sepsis Network guidelines align with SSC
EU: EAU 2024 primary guideline, SSC for sepsis principles
UK: NICE Sepsis guidelines + EAU concordant
US: SSC 2021 + IDSA guidelines for antibiotic selection
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Urosepsis Management (EAU 2024 + SSC 2021)?
The Urosepsis Management (EAU 2024 + SSC 2021) is a emergency clinical algorithm for Urology. It provides a structured decision tree to guide clinical decision-making, based on EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021.
What guideline is the Urosepsis Management (EAU 2024 + SSC 2021) based on?
This algorithm is based on EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021 (DOI: 10.1016/j.eururo.2024.03.035).
What are the limitations of the Urosepsis Management (EAU 2024 + SSC 2021)?
Known limitations include: Does not replace ICU-level sepsis management; Antibiotic choice depends on local resistance patterns; Complex cases require multidisciplinary input; Does not address pediatric urosepsis; Immunocompromised patients may present atypically. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Urosepsis Management (EAU 2024 + SSC 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free